AMPH
Closed
Amphastar P
23.34
+0.38 (+1.66%)
Last Update: 01 Jul 2025 23:00:00
Yesterday: 22.96
Day's Range: 22.89 - 24.52
Send
sign up or login to leave a comment!
When Written:
37.5
Amphastar Pharmaceuticals, Inc. is a pharmaceutical company that develops, manufactures, and markets generic and proprietary injectable, inhalation, and intranasal products. The company was founded in 1996 and is headquartered in Rancho Cucamonga, California. Amphastar's products are primarily used in hospitals and clinics for critical care and emergency medicine. Some of the company's key products include enoxaparin sodium injection, naloxone hydrochloride injection, and epinephrine injection. Amphastar also has a pipeline of products in various stages of development, including a nasal spray for the treatment of opioid overdose and a generic version of the drug Advair Diskus for the treatment of asthma and chronic obstructive pulmonary disease (COPD).
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!








